Virtue Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,918	Closed	-$515K	–	300
2024 Q2	$515K	Sell	5,918 -1,139	-16%	-$101K	0.09%	204
2024 Q1	$636K	Buy	+7,057	New	+$593K	0.11%	170
2023 Q4	–	Sell	-7,128	Closed	-$496K	–	189
2023 Q3	$648K	Hold	7,128	–	–	0.11%	176
2023 Q2	$648K	Sell	7,128 -276	-4%	-$24K	0.11%	176
2023 Q1	$647K	Sell	7,404 -516	-7%	-$40.6K	0.11%	162
2022 Q4	$591K	Buy	+7,920	New	+$610K	0.09%	169
2022 Q3	–	Sell	-2,215	Closed	-$211K	–	271
2022 Q2	$211K	Sell	2,215 -23,249	-91%	-$2.41M	0.03%	252
2022 Q1	$3M	Sell	25,464 -2,777	-10%	-$312K	0.47%	37
2021 Q4	$3.66M	Buy	28,241 +1,612	+6%	+$188K	0.54%	32
2021 Q3	$3.02M	Sell	26,629 -560	-2%	-$63.9K	0.53%	33
2021 Q2	$2.82M	Buy	27,189 +1,242	+5%	+$117K	0.56%	33
2021 Q1	$2.17M	Buy	25,947 +532	+2%	+$45K	0.51%	42
2020 Q4	$2.32M	Sell	25,415 -2,657	-9%	-$220K	0.57%	34
2020 Q3	$2.24M	Buy	28,072 +1,358	+5%	+$106K	0.55%	43
2020 Q2	$1.85M	Buy	+26,714	New	+$1.9M	0.43%	68
2020 Q1	–	Sell	-21,384	Closed	-$1.66M	–	88
2019 Q4	$1.66M	Buy	21,384 +5,529	+35%	+$432K	0.48%	44
2019 Q3	$1.16M	Buy	15,855 +5,484	+53%	+$385K	0.38%	89
2019 Q2	$639K	Buy	+10,371	New	+$627K	0.23%	116
2018 Q2	–	Sell	-42	Closed	-$2K	–	272
2018 Q1	$2K	Hold	42	–	–	﹤0.01%	484
2017 Q4	$2K	Buy	+42	New	+$1.54K	﹤0.01%	417